Olaplex Holdings, Inc. (NASDAQ:OLPX – Get Free Report) CFO Catherine Dunleavy sold 93,809 shares of Olaplex stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $1.26, for a total transaction of $118,199.34. Following the transaction, the chief financial officer directly owned 3,026,885 shares in the company, valued at $3,813,875.10. This represents a 3.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Olaplex Stock Up 4.2%
Shares of NASDAQ OLPX traded up $0.05 during trading on Monday, hitting $1.25. The stock had a trading volume of 1,389,924 shares, compared to its average volume of 1,785,522. The firm has a fifty day moving average of $1.54 and a two-hundred day moving average of $1.36. The company has a market capitalization of $836.75 million, a PE ratio of -125.00 and a beta of 2.24. The company has a debt-to-equity ratio of 0.40, a current ratio of 4.58 and a quick ratio of 4.00. Olaplex Holdings, Inc. has a 12 month low of $0.99 and a 12 month high of $1.84.
Olaplex (NASDAQ:OLPX – Get Free Report) last released its quarterly earnings results on Thursday, March 5th. The company reported $0.01 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.01. Olaplex had a negative net margin of 2.19% and a positive return on equity of 1.07%. The company had revenue of $105.12 million for the quarter, compared to analyst estimates of $104.21 million. During the same period last year, the firm earned $0.01 earnings per share. The firm’s revenue was up 4.4% on a year-over-year basis. As a group, equities research analysts forecast that Olaplex Holdings, Inc. will post 0.1 EPS for the current fiscal year.
Institutional Trading of Olaplex
Analyst Upgrades and Downgrades
Several research firms have commented on OLPX. Weiss Ratings reissued a “sell (d)” rating on shares of Olaplex in a research report on Thursday, January 22nd. Morgan Stanley set a $1.40 target price on Olaplex in a report on Tuesday, March 10th. Barclays set a $1.75 price target on Olaplex in a research report on Friday, January 16th. Jefferies Financial Group reiterated a “buy” rating on shares of Olaplex in a report on Wednesday, March 4th. Finally, Telsey Advisory Group reissued a “market perform” rating and issued a $2.00 price objective on shares of Olaplex in a research report on Monday, March 2nd. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Olaplex presently has an average rating of “Hold” and a consensus target price of $1.88.
Check Out Our Latest Report on Olaplex
About Olaplex
Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.
Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.
See Also
- Five stocks we like better than Olaplex
- The “secret weapon” behind Microsoft, Meta, Amazon, and Google
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Do this before SpaceX IPOs or be sorry
- Iran isn’t the real war
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.
